APPOINTMENTS: Array, Bioniz, Galmed, Marathon Pharma, Selecta and Valeant
Executive Summary
Former Allergan PLC CEO Dr. David Pyott has joined the board of and invested in emerging biotech Bioniz Therapeutics, while Valeant Pharmaceuticals International Inc. and Selecta Biosciences Inc. have also allotted new board members. Marathon Pharmaceuticals LLC, Array BioPharma Inc. and Galmed Pharmaceuticals Ltd. have made a series of executive appointments.